GLP-1 permission as a post came out of a walk in west London. Chelsea is a wealthy area of the city, with neighbourhoods made up of hedge fund managers, hereditary rich locals, captains of industry like INEOS’ Jim Radcliffe and wealthy foreigners who live in the UK on a seasonal basis.
Zeitgeist
This means that health clinics and pharmacies in the area can successfully sell services to private customers. So I wasn’t surprised to see a pharmacy offering a service to help with weight loss. These adverts are tapping into a global need to combat obesity. A sign of how big using GLP-1s for weight loss and weight management was an advert run during the Super Bowl by Hims & Hers. GLP-1 pioneer, Novo Nordisk for a brief time was the most valuable company in Europe, even more valuable than French luxury conglomerate LVMH.
And for well-off people, going private gives GLP-1 permission when used under the guidance of a healthcare professional to be used for aesthetic reasons rather being solely focused on the medical benefits of reducing obesity.
All of which makes sense why you would see weight loss consultations / services promoted at a pharmacy in Chelsea.
What the advertising got right?
Looking at the copywriting itself, it is solutions-focused with a clear call to action to speak to a member of staff to find out more. The copywriting is very much in line with CAP guidelines and ABPI guidelines.
What the advertising got wrong?
Policing of UK advertising seems to have created a belief that we suddenly operate in a more permissive regulatory and legal environment. GLP-1-based treatments have had some of the biggest commercial and cultural impact since Pfizer launched their erectile dysfunction treatment Viagra.
But despite these medicines being in the cultural zeitgeist there isn’t some exemption, a GLP-1 permission. GLP-1 weight management treatments are still prescription-only medicines and are still governed by the regulations that restrict branded communications to healthcare professionals (doctors, specialists, nurse prescribers, pharmacists) and patients that have already had the medicine prescribed to them.
Take this particular photo of the earlier poster series, In it you can clearly see the logos for both GLP-1 based weight management treatments. Both are prescription drugs, rather than over the counter medicines. This is illegal in the UK (and many other countries outside the United States).
At least we can say with some confidence that the notices were likely produced by the pharmacy, rather than facilitated by the pharma companies involved.
No pharmaceutical company would be pleased seeing their brand given equal treatment with a competitor.
If you are doing marketing for any business like this in the UK, know your CAP and ABPI codes.